Abstract
Objective
To share experience of over 15 years in hematopoietic stem cell transplantation in children with primary immunodeficiency disorders.
Design
Medical record review.
Setting
A referral center for pediatric hemato-oncological disorders.
Participants
Children (<18 y) diagnosed to have primary immune deficiencies who underwent hematopoietic stem cell transplantation between 2002 and August 2017.
Main outcome measures
Disease-free survival, morbidity and mortality.
Results
85 primary immunodeficiency disorder transplants were performed with engraftment noted in 80 (94%) transplants and an overall survival of 67%. The conditioning regimen was individualized based on the underlying immune defect. Mixed chimerism was noted in 20% children with 56% (9/16) remaining disease-free. Graft versus host disease was noted in 33 (39.2%) children with most seen in children with chronic granulomatous disease. Severe combined immune deficiency transplants were mainly complicated by infections. Immune cytopenias complicated Wiskott Aldrich syndrome and Hemophagocytic lymphohistiocytosis transplants. 29.4% (25/85) children underwent haploidentical transplant in our cohort with a survival of 70% in this group. Infectious complications were the most common cause of death.
Conclusion
Primary immunodeficiency disorders are curable in India when transplanted in centers with experienced and trained pediatric transplant physicians and intensivists.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Madkaikar M, Aluri J, Gupta S. Guidelines for Screening, Early Diagnosis, and Management of Severe Combined Immunodeficiency (SCID) in India. Indian J Pediatr. 2016;5:455–62.
Gupta S, Madkaikar M, Singh S, Sehgal S. Primary immunodeficiencies in India: A perspective. Ann N Y Acad Sci. 2012;1250:73–9.
Jindal AK, Pilania RK, Rawat A, Singh S. Primary immunodeficiency disorders in India – A situational review. Front Immunol. 2017;8:714.
Mitchell R, Nivison–Smith I, Anazodo A, Tiedemann K, Shaw P, Teague L, et al. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children’s Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Biol Blood Marrow Transplant. 2013;19:338–43.
Fox TA, Chakraverty R, Burns S, Carpenter B, Thomson K, Lowe D, et al. Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency. Blood. 2018;131:917–31.
Shah RM, Elfeky R, Nademi Z, Qasim W, Amrolia P, Chiesa R, et al. T–cell receptor αβ+ and CD19+ cell depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency. J Allergy Clin Immunol. 2018;141:1417–26–e1.
Fischer A, Landais P, Friedrich W, Gerritsen B, Fasth A, Porta F, et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: A report from the European Group for BMT and the European Group for Immunodeficiency. Blood. 1994;83:1149–54.
Slatter MA, Rao K, Amrolia P, Flood T, Abinun M, Hambleton S, et al. Treosulfan–based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. Blood. 2011;117:4367–75.
Buckley RH, Schiff SE, Schiff RI, Markert ML, Williams LW, Roberts JL, et al. Hematopoietic stem–cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508–16.
Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, et al. Transplantation of hematopoietic stem cells and long–term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better? J Allergy Clin Immunol. 2010;126:602–10.e1–11.
Kapoor N, Raj R. Hematopoietic stem cell transplantation for primary immune deficiency disorders. Indian J Pediatr. 2016;83:450–4.
Slatter MA, Boztug H, Pötschger U, Sykora KW, Lankester A, Yaniv I, et al. Treosulfan–based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non–malignant diseases. Bone Marrow Transplant. 2015;50:1536–41.
Hassan A, Lee P, Maggina P, Xu JH, Moreira D, Slatter M, et al. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency. J Allergy Clin Immunol. 2014;133:1660–6.
Borte S, von Döbeln U, Hammarström L. Guidelines for newborn screening of primary immunodeficiency diseases. Curr Opin Hematol. 2013;20:48–54.
Ghosh S, Gaspar HB. Gene therapy approaches to immunodeficiency. Hematol Oncol Clin North Am. 2017; 31:823–34.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uppuluri, R., Jayaraman, D., Sivasankaran, M. et al. Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency Disorders: Experience from a Referral Center in India. Indian Pediatr 55, 661–664 (2018). https://doi.org/10.1007/s13312-018-1354-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-018-1354-9